Stocks and Investing
Stocks and Investing
Fri, August 12, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jonathan Chang Maintained (VINC) at Buy with Decreased Target to $5 on, Aug 12th, 2022
Jonathan Chang of SVB Leerink, Maintained "Vincerx Pharma, Inc." (VINC) at Buy with Decreased Target from $6 to $5 on, Aug 12th, 2022.
Jonathan has made no other calls on VINC in the last 4 months.
There are 3 other peers that have a rating on VINC. Out of the 3 peers that are also analyzing VINC, 0 agree with Jonathan's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Jonathan
- Li Watsek of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $8 on, Wednesday, June 8th, 2022
- Matthew Barcus of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $4 on, Tuesday, June 7th, 2022
- Kalpit Patel of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $6 on, Tuesday, June 7th, 2022
Contributing Sources